Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease characterized by chronic inflammation affecting various organs. Current treatments aim to manage symptoms and reduce disease activity, but there is a continuous need for novel therapeutic agents. Emerging research into peptides, such as ARA-290 (Cibinetide), offers a new frontier in understanding and potentially treating autoimmune conditions. NINGBO INNO PHARMCHEM CO.,LTD. is facilitating this research by providing high-quality ARA-290.
ARA-290, a synthetic peptide derived from EPO, is known for its tissue-protective and anti-inflammatory properties, distinct from EPO's primary role in red blood cell production. Preliminary studies suggest that ARA-290 may play a role in modulating the immune system and reducing inflammation, making it a candidate for investigating treatments for SLE. Researchers can purchase ARA-290 from NINGBO INNO PHARMCHEM CO.,LTD. to conduct studies that explore these immunomodulatory effects.
The peptide's potential to decrease inflammatory pathways through paracrine signaling is a key aspect being investigated. This could translate into a more targeted approach to managing the systemic inflammation characteristic of SLE. NINGBO INNO PHARMCHEM CO.,LTD. ensures the quality of the Cibinetide they supply, which is critical for accurate and reliable research outcomes in complex diseases like lupus. The company also offers competitive pricing for ARA-290, supporting extensive research efforts.
In addition to its potential in autoimmune diseases, ARA-290 is also studied for its neuroprotective effects and its role in wound repair, particularly in diabetic patients. These diverse applications highlight the peptide's versatility. NINGBO INNO PHARMCHEM CO.,LTD.'s commitment to providing high-purity research chemicals like ARA-290 is instrumental in advancing our understanding of these complex biological processes. Exploring the ARA-290 pain relief mechanism may also offer symptomatic relief for SLE patients who often suffer from associated pain.
For researchers focusing on autoimmune diseases and inflammatory conditions, NINGBO INNO PHARMCHEM CO.,LTD. offers a reliable source for ARA-290. By supporting investigations into this promising peptide, the company contributes to the ongoing development of novel therapeutic strategies for systemic lupus erythematosus and other challenging health issues.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
